Ansell reports higher sales, earnings amid tariff pressure

Melbourne, Australia – Ansell has reported double-digit earnings growth for the fiscal year ended 30 June, with higher sales across its two industrial and healthcare businesses.

The Australian protective equipment manufacturer posted sales of $2.15 billion (€1.85 billion) for fiscal 2026, up 6.8% from $2.00 billion the previous year.

Adjusted EBIT rose 14% year-on-year to $321.9 million, from $282.1 million, with the adjusted EBIT margin increasing to 15.0% from 14.1%, Ansell said in its recently released full-year results.

Ansell attributed the improved profitability partly to sales growth in “higher margin market segments” and supply-chain productivity.

The gains were partly offset by pricing measures introduced to counter US tariffs and higher costs stemming from the Middle East crisis, which Ansell said were “moderately dilutive” to its margin.

The manufacturer said it had offset the impact of higher US tariffs through “sourcing optimisation initiatives and price increases,” while maintaining pricing flexibility in the event of further changes to tariff policies.

Ansell also said it was pursuing refunds for tariffs paid prior to a US Supreme Court ruling in February, receiving an initial $12 million in July.

The US remained the group's largest market, accounting for 43% of full year sales, with Ansell reporting that US growth was 1.8 times the rate recorded by the group overall.

In particular, US growth strengthened during the second half of the year, particularly across industrial and scientific end-markets, Ansell added.

Within the Industrial division, revenue increased 5.4% to $947 million, from $898 million in the previous fiscal year.

Adjusted EBIT increased 9.7% to $170 million, compared with $155 million the previous year, lifting the segment's adjusted EBIT margin to 18% from 17.3%.

Ansell linked the sales performance to growth in key vertical markets, including aerospace and defence, as well as “second-half momentum in US industrial markets.”.

Healthcare sales increased 8% year-on-year to $1.2 billion from $1.1 billion as adjusted EBIT climbed 20.3% to $170 million, from $142 million the year before.

Ansell cited “improved second-half volume trends” and higher demand for cleanroom solutions, particularly in the US.